Core Viewpoint - KULR Technology Group, Inc. will hold a conference call on May 15, 2025, to discuss its financial results for the first quarter ended March 31, 2025, with results to be released prior to the call [1][3]. Company Overview - KULR Technology Group, Inc. is a leader in advanced energy management solutions, specializing in energy storage solutions for space, aerospace, and defense [4]. - The company utilizes in-house battery design expertise and offers a comprehensive cell and battery testing suite, along with battery fabrication and production capabilities [4]. - KULR has committed to allocating up to 90% of its surplus cash to the acquisition of bitcoin as part of its treasury program [4]. Conference Call Details - The conference call will take place at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) [1][3]. - Interested parties can submit questions to be addressed during the call, with a deadline for submissions set for 8:00 a.m. ET on May 12, 2025 [2]. - Registration is required to access the call, and details will be provided via email after registration [3]. Investor Relations - For further inquiries, KULR Technology Group can be contacted via phone at 858-866-8478 x 847 or through email at ir@kulr.ai [6].

BANGKOK, May 06, 2025 (GLOBE NEWSWIRE) -- Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced that its management will present at the 53rd Annual J.P. Morgan Global Technology, Media and Communications Conference in Boston, MA. The Fabrinet presentation is scheduled for Thursday, May 15, 2025 at 10:00 a.m. EDT (7:00 a.m. PDT). A live webca ...

Dallas, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- CompX International Inc. (NYSE American: CIX) announced today net sales of $40.3 million for the first quarter of 2025 compared to $38.0 million in the same period of 2024. Operating income was $5.9 million in the first quarter of 2025 compared to $3.7 million in the same period of 2024. Net income was $5.1 million, or $.42 per basic and diluted common share, for the first quarter of 2025 compared to $3.7 million, or $.31 per basic and diluted common share, in ...

HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Powell Industries, Inc. (NASDAQ: POWL), a leading supplier of custom-engineered solutions for the management, control and distribution of electrical energy, today announced results for the second quarter of Fiscal 2025 ended March 31, 2025. All comparisons are to the second quarter of Fiscal 2024, unless otherwise noted. Second Quarter Key Financial Highlights: Revenues totaled $279 million, an increase of 9%;Gross profit of $83 million, or 29.9% of revenue;Net inc ...

HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE: MRC) today announced first quarter 2025 results from continuing operations. First Quarter 2025 Financial Highlights: Operating cash flows provided by continuing operations of $21 million Sales of $712 million, a 7% increase compared to the fourth quarter of 2024Gross profit, as a percentage of sales, of 19.9%Adjusted Gross Profit, as a percentage of sales, of 21.5%Net income from continuing operations of $8 millionAdjusted EBITDA of $36 millio ...

SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced financial results for the first quarter of 2025. First quarter revenue was $7.4 billion, gross margin was 50%, operating income was $806 million, net income was $709 million and diluted earnings per share was $0.44. On a non-GAAP(*) basis, gross margin was 54%, operating income was $1.8 billion, net income was $1.6 billion and diluted earnings per share was $0.96. “We delivered an outstanding start to 2025 as year-over-ye ...

PALO ALTO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) will present a live audio webcast of a conference call to review financial results for the second fiscal quarter ended April 30, 2025 on Wednesday, May 28, 2025 at 5:00 p.m. ET / 2:00 p.m. PT. The webcast will be available at www.hp.com/investor/2025Q2Webcast. A replay of the audio webcast will be available at the same website shortly after the call and will remain available for approximately one year. About HP Inc. HP Inc. (NYSE: HPQ) ...

CALGARY, Alberta, May 06, 2025 (GLOBE NEWSWIRE) -- Wilmington Capital Management Inc. (TSX: WCM.A, WCM.B) (“Wilmington” or the “Corporation”) reported a net loss for the three months ended March 31, 2025, of $0.2 million or ($0.01) per share compared to net income of $1.3 million or $0.10 per share for the same period in 2024. First Quarter 2025 The Corporation reported a net loss for the three months ending March 31, 2025 of $0.2 million or ($0.01) per share compared to net income of $1.3 million or $0.1 ...

Core Insights - Genelux Corporation reported a productive first quarter of 2025, establishing a strong foundation for advancing its lead product, Olvi-Vec, in various cancer indications [2][3] Pipeline Highlights - The FDA provided encouraging feedback on the OnPrime Phase 3 trial for Olvi-Vec in resistant/refractory ovarian cancer, indicating potential for traditional approval if a meaningful progression-free survival advantage is demonstrated [3] - Preliminary data from the Phase 1b/2 trial of Olvi-Vec in small cell lung cancer showed a 71% disease control rate, with significant tumor reductions observed in participants [4] - Patient enrollment is increasing in the ongoing Phase 2 trial for recurrent non-small cell lung cancer, with interim results expected in the second half of 2025 [5] Business Updates - Matthew Pulisic was appointed as the new Chief Financial Officer, bringing over 19 years of experience in the biopharmaceutical industry [6] - The company completed an underwritten offering of 3,000,000 shares at $3.50 per share, raising approximately $10.5 million to strengthen its balance sheet and extend its operational runway [7] Financial Results - As of March 31, 2025, cash, cash equivalents, and short-term investments totaled $35.1 million, expected to provide runway into the third quarter of 2026 [8] - Research and development expenses increased to $4.7 million from $4.0 million year-over-year, primarily due to higher clinical trial costs [9] - General and administrative expenses decreased to $3.1 million from $4.1 million year-over-year [10] - The net loss for the first quarter of 2025 was $7.5 million, or $0.21 per share, compared to a net loss of $7.9 million, or $0.29 per share, in the same period of 2024 [11]

Core Viewpoint - Jin Medical International Ltd. has received a deficiency letter from Nasdaq regarding non-compliance with the minimum bid price requirement for its ordinary shares, which must be at least $1.00 per share for continued listing on The Nasdaq Capital Market [1][2]. Compliance Status - The deficiency notice does not immediately affect the listing status of the ordinary shares, and the company has a compliance period of 180 calendar days, until October 29, 2025, to regain compliance [2][3]. - If the closing bid price reaches or exceeds $1.00 for a minimum of 10 consecutive business days before the deadline, the company will be notified of compliance [2]. Reverse Stock Split - The company may implement a reverse stock split to regain compliance, which must be completed no later than ten business days prior to October 29, 2025 [2][4]. - If the company fails to regain compliance within the initial 180-day period, it may be eligible for an additional compliance period, provided it meets other listing requirements [3][4]. Company Overview - Jin Medical International Ltd. was founded in 2006 and is headquartered in Changzhou, Jiangsu Province, China, focusing on designing, developing, manufacturing, and marketing wheelchairs and living aids for people with disabilities and the elderly [5]. - The company operates two manufacturing plants totaling approximately 230,000 square feet and is establishing a new facility of 430,000 square feet in Chuzhou, Anhui Province [5]. - Jin Medical has over 40 distributors in China and more than 20 international distributors, with a significant portion of its wheelchair products sold to Japan and China [5].